When chemotherapy and radiation fail, some adult patients with B-cell non-Hodgkin’s lymphoma or children with acute lymphoblastic leukemia have a new treatment option called CAR T-cell therapy. Yescarta is the CAR T-cell therapy that’s FDA-approved to treat patients with B-cell non-Hodgkin’s lymphoma; it shrinks the tumors in 70-80% of patients.
But with this new therapy come side effects that are different from those of other...
A patient writes, “The Astros will win the World Series next year,” in bold print as Jaquelin Velasquez watches. The clinical nurse in Lymphoma...
A cancer diagnosis can provoke a range of emotions and prompt endless questions. So throughout the year, we shared dozens of insights from...
Seeking additional treatment for non-Hodgkin’s lymphoma presented a challenge for Emily Dumler in 2013.
At the time, she and her husband, Scott, had three young children, and they all lived in Kansas City. But the chemotherapy and stem cell transplant she’d already received locally hadn’t worked, and the CAR T-cell therapy clinical trial Emily wanted to try was only available at MD Anderson in Houston, about 650 miles away by air...
I am a numbers person. So, when my wife, Emily, was diagnosed with non-Hodgkin’s lymphoma in August 2013, I turned to the internet for some...
CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell...
Before I was on a clinical trial, I felt sorry for patients participating in them. I considered clinical trials a last-ditch effort, and felt...